Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pulmonology

What Does a Low DLCO Indicate in COPD? Causes Explained

At a Glance

In COPD, a low DLCO most often suggests emphysema-related damage that reduces gas exchange, but anemia, pulmonary hypertension, and other lung problems can also lower it. DLCO alone does not determine COPD stage or the need for oxygen; blood oxygen testing guides oxygen decisions.

A low DLCO test result means your lungs have a reduced capacity to transfer carbon monoxide—and, by extension, oxygen—from your air sacs into your bloodstream [1]. In people with chronic obstructive pulmonary disease (COPD), a low DLCO is most often associated with emphysema, which destroys the delicate structures where gas exchange happens [2][3]. However, a low score can also be related to anemia, high blood pressure in the lungs (pulmonary hypertension), or other lung conditions [4][5].

While a low DLCO is an important clue that helps explain why you might feel breathless, it is not a direct measure of your COPD “stage” and does not define your life expectancy. Furthermore, a low DLCO does not automatically mean you need supplemental oxygen; oxygen decisions are based on direct measurements of your blood oxygen levels, not your DLCO score [6].

How Emphysema Affects Your DLCO

DLCO stands for diffusing capacity of the lungs for carbon monoxide. During the test, you inhale a tiny, safe amount of carbon monoxide gas [1]. The test measures how easily that gas moves from your lungs into your red blood cells.

When COPD involves a lot of emphysema, the walls of the tiny air sacs (alveoli) and their surrounding blood vessels are damaged [2]. This reduces the total surface area available for gas to cross into the blood. Studies show that a lower DLCO strongly correlates with the amount of emphysema visible on a chest CT scan [3][7]. Keep in mind that a normal DLCO does not rule out COPD (especially if your COPD is mostly chronic bronchitis), and a low DLCO does not by itself prove you have emphysema.

How Doctors Interpret the Number

Receiving an abnormal lung-test result can be worrying, but the number is just one part of your evaluation. Doctors look at several factors to understand your DLCO:

  • Percent Predicted and LLN: Your result is compared to what is expected for someone of your age, height, sex, and birth sex, often expressed as a percentage or checked against the “lower limit of normal” (LLN) [6].
  • Context: The number is always interpreted alongside your breathing tests (spirometry), lung volumes, and symptoms [8].

When to Look Beyond Emphysema

Sometimes, a DLCO result is disproportionately lower than what doctors would expect based on your spirometry, specifically your FEV1 (the amount of air you can forcibly exhale in one second) [9]. When FEV1 is relatively normal but DLCO is very low, doctors broaden their search to include:

  • Pulmonary hypertension: High blood pressure in the lung’s arteries [10]. If suspected, an echocardiogram (ultrasound of the heart) can estimate the probability of this condition, though a procedure called right-heart catheterization is required to confirm the diagnosis and measure exact pressures [11].
  • Interstitial lung disease (ILD): A group of conditions that cause inflammation or scarring in the lung tissue [12].
  • Other factors: Blood clots in the lungs, low overall lung volume, or poor test performance.

The Role of Anemia and Smoking

Your DLCO score relies on hemoglobin, the protein in red blood cells that carries oxygen and binds to the carbon monoxide used in the test. If you have anemia (low hemoglobin), less gas is absorbed during the test. This genuinely lowers your carbon monoxide uptake [5]. To make the interpretation fair, laboratories apply a mathematical correction based on a recent blood test to give you a “hemoglobin-adjusted” DLCO [13].

Additionally, smoking immediately before your test increases the carbon monoxide already in your blood (carboxyhemoglobin), which can lower your DLCO result [14]. Always follow the pulmonary lab’s instructions regarding smoking, inhaler use, and exercise before your test.

How DLCO Connects to Symptoms and Exercise

Breathlessness is complex and can be caused by airflow blockage, deconditioning, or heart issues. However, a low DLCO may help explain why you feel more breathless during daily activities [8][6].

People with a low DLCO are more likely to experience oxygen desaturation (a drop in blood oxygen levels) during physical exertion [6]. Because of this, your doctor might recommend a 6-minute walk test or cardiopulmonary exercise testing (CPET)—a specialized test on a bike or treadmill—to measure your actual oxygen levels during movement and determine if you would benefit from supplemental oxygen when active [6][15].

Tracking DLCO Over Time

For many people with COPD, DLCO declines slowly over time [16]. There is no single universal schedule for repeating this test; your doctor will individualize your testing timeline based on your symptoms, treatment changes, and baseline results. When checking for changes, it is best to compare tests done at the same laboratory, as different machines and calculation methods can cause slight variations [17].

Safety Warning: Routine testing is for tracking long-term changes. If you experience sudden or severe breathlessness, breathlessness at rest, chest pain, fainting, confusion, blue lips, or a drop in your oxygen saturation below your prescribed threshold, do not wait for a pulmonary function test. Seek emergency medical care immediately.

Common questions in this guide

What is the most common reason for a low DLCO in COPD?
In a person with COPD, a low DLCO is often associated with emphysema. Emphysema damages the air sacs and nearby blood vessels, leaving less surface area for oxygen to move into the blood. Anemia, high blood pressure in the lung arteries, and other lung problems can also lower the result.
Does a low DLCO prove that I have emphysema?
No. A low result can support the possibility of emphysema, but it can also be caused by anemia, high blood pressure in the lung arteries, lung scarring, blood clots, low lung volume, or an inadequate test. Doctors interpret it with spirometry, other lung measurements, symptoms, and sometimes a chest CT scan.
Does a low DLCO mean my COPD is severe or shorten my life expectancy?
Not by itself. DLCO is one measure of how gases move from the lungs into the blood, and it is not a direct measure of COPD stage or life expectancy. Clinicians combine it with symptoms, breathing tests, lung volumes, imaging, and blood oxygen measurements.
Will I need supplemental oxygen if my DLCO is low?
Not necessarily. The decision is based on direct measurements of blood oxygen, including whether oxygen falls during activity, rather than on DLCO alone. A six-minute walk test or cardiopulmonary exercise test may be used to check oxygen levels while you move.
Can anemia or smoking change my DLCO result?
Yes. Low hemoglobin from anemia can make less carbon monoxide bind during the test, so laboratories may adjust the result using a recent blood count. Smoking immediately before testing can raise carbon monoxide in the blood and lower the measured DLCO, so follow the laboratory's preparation instructions.
What should be checked if my DLCO is much lower than expected?
Your clinician may compare it with the amount of air you can force out in one second, called FEV1, along with other lung tests, symptoms, and scans. If the result is disproportionately low, they may evaluate for pulmonary hypertension, lung scarring, blood clots, anemia, or other causes and may order an echocardiogram or exercise oxygen test.
How often should I repeat a DLCO test?
There is no single schedule for everyone with COPD. Your clinician may base the timing on your symptoms, treatment changes, and previous result; comparing tests from the same laboratory can make small changes easier to interpret.

Get notified when new evidence is published on chronic obstructive pulmonary disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Measurement and Significance of the Diffusing Capacity of the Lung for Carbon Monoxide.

    Balasubramanian A

    Clinics in chest medicine 2025; (46(3)):425-435 doi:10.1016/j.ccm.2025.04.003.

    PMID: 40769590
  2. 2

    Diffusing capacity in chronic obstructive pulmonary disease assessment: A meta-analysis.

    Ni Y, Yu Y, Dai R, Shi G

    Chronic respiratory disease 2021; (18()):14799731211056340 doi:10.1177/14799731211056340.

    PMID: 34855516
  3. 3

    Relationships between diffusing capacity for carbon monoxide (DLCO), and quantitative computed tomography measurements and visual assessment for chronic obstructive pulmonary disease.

    Nambu A, Zach J, Schroeder J, et al.

    European journal of radiology 2015; (84(5)):980-5.

    PMID: 25704753
  4. 4

    Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohort.

    Dauriat G, Reynaud-Gaubert M, Cottin V, et al.

    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2021; (40(9)):1009-1018 doi:10.1016/j.healun.2021.04.021.

    PMID: 34218966
  5. 5

    Quantitative Vertebral Bone Density Seen on Chest CT in Chronic Obstructive Pulmonary Disease Patients: Association with Mortality in the Korean Obstructive Lung Disease Cohort.

    Hwang HJ, Lee SM, Seo JB, et al.

    Korean journal of radiology 2020; (21(7)):880-890 doi:10.3348/kjr.2019.0551.

    PMID: 32524788
  6. 6

    Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.

    Elbehairy AF, O'Donnell CD, Abd Elhameed A, et al.

    Journal of applied physiology (Bethesda, Md. : 1985) 2019; (127(4)):1107-1116 doi:10.1152/japplphysiol.00341.2019.

    PMID: 31369329
  7. 7

    Stronger Associations of Centrilobular Than Paraseptal Emphysema With Longitudinal Changes in Diffusing Capacity and Mortality in COPD.

    Shiraishi Y, Tanabe N, Shimizu K, et al.

    Chest 2023; (164(2)):327-338 doi:10.1016/j.chest.2023.01.034.

    PMID: 36736486
  8. 8

    Diffusing Capacity of Carbon Monoxide in Assessment of COPD.

    Balasubramanian A, MacIntyre NR, Henderson RJ, et al.

    Chest 2019; (156(6)):1111-1119 doi:10.1016/j.chest.2019.06.035.

    PMID: 31352035
  9. 9

    Endotyping COPD: hypoxia-inducible factor-2 as a molecular "switch" between the vascular and airway phenotypes?

    Myronenko O, Foris V, Crnkovic S, et al.

    European respiratory review : an official journal of the European Respiratory Society 2023; (32(167)) doi:10.1183/16000617.0173-2022.

    PMID: 36631133
  10. 10

    Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD.

    Balasubramanian A, Hemnes AR, Brittain EL, et al.

    Thorax 2026; (81(6)):524-532 doi:10.1136/thorax-2025-223921.

    PMID: 41309285
  11. 11

    The Challenge to Decide between Pulmonary Hypertension Due to Chronic Lung Disease and PAH with Chronic Lung Disease.

    Olschewski H

    Diagnostics (Basel, Switzerland) 2021; (11(2)) doi:10.3390/diagnostics11020311.

    PMID: 33671914
  12. 12

    Isolated, reduced diffusing capacity for carbon monoxide in the population - relations to symptoms, smoking and comorbidities.

    Hamrefors V, Westerbergh J, Behndig A, et al.

    BMC pulmonary medicine 2026; (26(1)).

    PMID: 42675482
  13. 13

    Clinical, Functional, and Comorbid Characteristics of COPD Patients with Impaired Diffusing Capacity: A Cross-Sectional Study.

    Tang L, Jiang Y

    Journal of clinical medicine 2026; (15(10)) doi:10.3390/jcm15103861.

    PMID: 42194821
  14. 14

    Independent Prognostic Value of Pulmonary Diffusing Capacity in Nonsmoking Patients with Chronic Heart Failure.

    Nakamura K, Kanzaki H, Okada A, et al.

    International heart journal 2019; (60(2)):366-373 doi:10.1536/ihj.18-420.

    PMID: 30799383
  15. 15

    Utility of Cardiopulmonary Exercise Testing in Chronic Obstructive Pulmonary Disease: A Review.

    Behnia M, Sietsema KE

    International journal of chronic obstructive pulmonary disease 2023; (18()):2895-2910 doi:10.2147/COPD.S432841.

    PMID: 38089541
  16. 16

    Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex.

    Casanova C, Gonzalez-Dávila E, Martínez-Gonzalez C, et al.

    Chest 2021; (160(2)):481-490 doi:10.1016/j.chest.2021.03.069.

    PMID: 33878339
  17. 17

    Assessing the applicability of the new Global Lung Function Initiative reference values for the diffusing capacity of the lung for carbon monoxide in a large population set.

    Wardyn PM, de Broucker V, Chenivesse C, et al.

    PloS one 2021; (16(1)):e0245434 doi:10.1371/journal.pone.0245434.

    PMID: 33445178

This page is for informational purposes only and does not constitute medical advice. Ask your clinician or pulmonologist to interpret your DLCO with your blood count, breathing tests, oxygen levels, and symptoms.